IP Library Granted Patent US 10,314,942
Granted Patent B2
US 10,314,942 · App. 14/755,931 · Granted Jun 11, 2019

Manufacture of biomaterial implants via three-dimensional printing technology

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,314,942
App. No.
14/755,931
Granted
Jun 11, 2019
Kind
B2
Abstract

The present invention relates to the manufacture of shaped biomaterial-based implants via three-dimensional printing technology.

Claims (35)

1. A method of generating a three-dimensional biomaterial-based implant, comprising:

visualizing an implantation site;

producing a mold comprising dimensions of the implantation site by three-dimensional printing;

placing a biomaterial in the mold wherein a shape of the biomaterial is at least one of a fiber, a shard, and a strip;

applying a pressure to the biomaterial in the mold; and

drying the biomaterial in the mold to form the biomaterial-based implant, wherein the void to fiber ratio of the implant is between about 1:99 to about 1:11, wherein the drying step heats the mold to a temperature between about 30° C. to about 80° C.; and

incorporating a separate medical implant and the biomaterial-based implant.

2. The method of claim 1 , wherein the visualization is selected from at least one of X-ray, ultrasound, CT imaging, and MRI imaging.

3. The method of claim 1 , wherein the visualization of the implantation site comprises imaging implantation sites in multiple patients.

4. The method of claim 3 , wherein the imaging multiple implantation sites in the multiple patients provides a representative image of an implantation site type.

5. The method of claim 1 , wherein the visualization of the implantation site occurs by imaging the implantation site of a single patient.

6. The method of claim 1 , wherein the biomaterial comprises at least two materials selected from the group consisting of a bone, a connective tissue, a tendon, a pericardium, a dermis, a cornea, a dura matter, a fascia, a heart valve, a ligament, a capsular graft, a cartilage, a collagen, a nerve, a placental tissue, and combinations thereof.

7. The method of claim 6 , wherein the biomaterial is the bone and wherein the bone material is at least one of cortical, cancellous or a combination thereof.

8. The method of claim 6 , wherein the biomaterial is the bone, and wherein the bone is at least one of demineralized, partially demineralized, or fully mineralized.

9. The method of claim 1 , wherein at least one additive is included with the biomaterial within the mold.

10. The method of claim 1 , further comprising contacting the biomaterial in the mold with a binding agent selected from the group consisting of a glue, a gum, a sugar, a polysaccharide, a cellulose ether, a resin, and combinations thereof.

11. The method of claim 1 , wherein the biomaterial is around a separate material within the mold.

12. The method of claim 11 , wherein the separate material is biocompatible.

13. The method of claim 1 , wherein the biomaterial further comprises a second shape of at least one of a powder and a particle.

14. A method of generating a three-dimensional biomaterial-based implant, comprising:

visualizing an implantation site; and

producing the three-dimensional biomaterial-based implant comprising a biomaterial to the dimensions of the implantation site, wherein a shape of the biomaterial of the three-dimensional biomaterial-based implant is at least one of a powder, a fiber, a particle, a shard, and a strip, wherein a material of the biomaterial is selected from the group consisting of a bone, a connective tissue, a tendon, a pericardium, a dermis, a cornea, a dura matter, a fascia, a heart valve, a ligament, a capsular graft, a cartilage, a collagen, a nerve, a placental tissue, and combinations thereof, wherein the implant is compressible to between about 5% of its original size to about 80% of its original size, and wherein the biomaterial-based implant further comprises a separate medical implant.

15. The method of claim 14 , wherein the visualization is selected from at least one of X-ray, ultrasound, CT imaging, and MM imaging.

16. The method of claim 14 , wherein the visualization of the implantation site comprises imaging implantation sites in multiple patients.

17. The method of claim 16 , wherein the imaging of the multiple implantation sites in the multiple patients provides a representative image of the implantation site.

18. The method of claim 14 , wherein the visualization of the implantation site comprises imaging the implantation site of a single patient.

19. The method of claim 14 , wherein the producing of the three-dimensional biomaterial-based implant comprises three-dimensional printing the implant.

20. The method of claim 14 , wherein the biomaterial is bone and wherein the bone material is at least one of a cortical bone, or a cancellous bone.

21. The method of claim 14 , wherein the biomaterial is the bone, and wherein the bone is at least one of a demineralized bone, partially demineralized bone, or fully mineralized bone.

22. A method of forming a biomaterial-based implant, comprising:

combining a biomaterial and a binding agent in a three-dimensional printer to form a combined material; and

printing the combined material to create an implant of desired dimensions, wherein the biomaterial-based implant is three-dimensionally printed into a separate medical implant in order to be implanted into a patient as a hybrid implant unit.

23. The method of claim 22 , wherein the biomaterial is selected from the group consisting of bone, connective tissue, tendon, pericardium, dermis, cornea, dura matter, fascia, heart valve, ligament, capsular graft, cartilage, collagen, nerve, placental tissue, and combinations thereof.

24. The method of claim 22 , wherein the binding agent is selected from the group including a glue, a gum, a sugar, a polysaccharide, a cellulose ether, a resin, and combinations thereof.

25. The method of claim 22 , wherein the three-dimensional printing process is selected from the group consisting of fused filament fabrication, plaster-based three-dimensional printing, selective laser sintering, selective heat sintering, and direct ink writing.

Assignments (10)
SECURITY INTEREST Recorded Aug 11, 2024
From: XTANT MEDICAL, INC.; BACTERIN INTERNATIONAL, INC.; X-SPINE SYSTEMS, INC.; SURGALIGN SPV, INC.; XTANT MEDICAL HOLDINGS, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 068539/0492 →
SECURITY INTEREST Recorded Aug 11, 2024
From: XTANT MEDICAL, INC.; BACTERIN INTERNATIONAL, INC.; X-SPINE SYSTEMS, INC.; SURGALIGN SPV, INC.; XTANT MEDICAL HOLDINGS, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 068539/0665 →
RELEASE OF SECURITY INTEREST Recorded Jun 18, 2021
From: ROS ACQUISITION OFFSHORE LP
To: BACTERIN INTERNATIONAL, INC.; X-SPINE SYSTEMS, INC.
Reel/Frame 056627/0795 →
RELEASE OF SECURITY INTEREST Recorded Jun 4, 2021
From: SILICON VALLEY BANK
To: XTANT MEDICAL, INC.; XTANT MEDICAL HOLDINGS, INC.; BACTERIN INTERNATIONAL, INC.; X-SPINE SYSTEMS, INC.
Reel/Frame 056493/0457 →
SECURITY INTEREST (TERM) Recorded May 21, 2021
From: XTANT MEDICAL HOLDINGS, INC.; XTANT MEDICAL, INC.; BACTERIN INTERNATIONAL, INC.; X-SPINE SYSTEMS, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 056323/0586 →
SECURITY INTEREST (REVOLVING) Recorded May 21, 2021
From: XTANT MEDICAL HOLDINGS, INC.; XTANT MEDICAL, INC.; BACTERIN INTERNATIONAL, INC.; X-SPINE SYSTEMS, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 056323/0536 →
RELEASE OF SECURITY INTEREST Recorded May 20, 2021
From: ROS ACQUISITION OFFSHORE LP
To: BACTERIN INTERNATIONAL, INC.; X-SPINE SYSTEMS, INC.
Reel/Frame 056323/0218 →
SECURITY AGREEMENT Recorded Jun 6, 2016
From: XTANT MEDICAL HOLDINGS, INC.; BACTERIN INTERNATIONAL, INC.; X-SPINE SYSTEMS, INC.; XTANT MEDICAL, INC.
To: SILICON VALLEY BANK
Reel/Frame 038884/0063 →
SECURITY INTEREST Recorded Aug 3, 2015
From: BACTERIN INTERNATIONAL, INC.; X-SPINE SYSTEMS, INC.
To: ROS ACQUISITION OFFSHORE, LP
Reel/Frame 036252/0338 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2015
From: MANSFIELD, MICHAEL; COX, DANIEL
To: BACTERIN INTERNATIONAL, INC.
Reel/Frame 035958/0417 →